VRIO Analysis

Tangible Resources  Intangible Resources

 Brand Awareness Is sustained
 New Products Are they Valuable in Are they Rare in the
Are they difficult to competitive
 Relation with doctors and medical Factors the pharmaceutical pharmaceutical
imitate in the advantage Competitive

pharmaceutical supported by the Positioning
Human Resource Industry? Industry? Industry? organizational
practitioners structure?
 Facility for manufacturing
 Goodwill from Acquisition
 R&D
 Patents New
Products Yes No No No Competitive Parity
 
  Human
Remarks/Suggestions: Resource Yes Yes No No Competitive Parity

1. Enhance the production of technologically complex products and invest in creating

Facility for Competetive
manufacturi Yes No Yes No advantageous
patents so that the New products are inimitable and rare. ng Partly

2. Secure the key Human Resource as the Brainworks are rare and losing Human Resource
R&D Yes No Yes Yes Competitive
may work in favour of competitor in several ways. Advantage
3. Improve innovative marketing. Surrogate Marketing can be utilised to gain customers Brand Competitive
Awareness Yes No No No Disadvantage
trust on the Generics of the Brand as pharmaceutical products are less suited for
mainstream marketing. MRs based marketing should be enhanced prescription drugs. Goodwill Competitve
with Yes Yes No Yes
Disadvantage
4. Research and Development should be highly focussed. The innovators in acquisition

pharmaceutical are the leaders of the industry. Competitve

Patents Yes Yes Yes Yes Disadvantage
5. Continually innovate to gain operational efficiency and further its position globally.
Relationship
with doctors Sustained
and Yes Yes Yes Yes competitive
practitioner advantage
Overall positioning in industry: Competitively advantageous s